PROTAC survivin degrader-1

Overview

PROTAC survivin degrader-1 is an orally active, CNS-penetrant survivin -targeting PROTAC . PROTAC survivin degrader-1 induces degradation of survivin via the ubiquitin proteasome system. PROTAC survivin degrader-1 can be used for the research of glioblastoma. (Pink: Survivin ligand ( HY-186213 ); Blue: Cereblon ligand ( HY-W453715 ); Black: linker).

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > CNS Neoplasm | Products > Disease Areas > Glioma | Products > Disease Areas > Glioblastoma | Products > Disease Areas > Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PROTACs | Products > Signaling Pathways > Survivin | Products > Signaling Pathways > PARP

Product Information

• Catalog No.: HY-186212
• CAS No.: 3079079-69-6
• Molecular Formula: C48H43ClFN7O7
• Molecular Weight: 884.35
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source